We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

19 May 2026 - 22 May 2026
17 Jun 2026 - 19 Jun 2026
05 Oct 2026 - 06 Oct 2026

High-power MRI Helps Surgeons Predict Cancer Outcomes

By HospiMedica staff writers
Posted on 26 Jan 2007
A surgical team has found that using a 3-Tesla magnetic resonance imaging (MRI) scanner in surgical decision-making provides a new degree of potential to predict surgical outcomes that improves patient care by decreasing the possibility of unsuccessful tumor-removal surgeries. More...


In their study, published the December 2006 issue of the Journal of Neurosurgery, clinicians from the Mayo Clinic (Rochester, MN, USA) reported on a case study of five patients. Four suffered from neurofibromatosis, a disorder with a predisposition to nerve-related tumors. All patients suffered from growths called sciatic notch, dumbbell-shaped tumors. The tumors were benign, but resulted in neurologic dysfunction and disabling pain.

"In the past, if surgeons couldn't tell prior to surgery where the exact location of the large tumor was in relation to the sciatic nerve, it meant they couldn't predict in which cases surgery could be performed safely,” explained Robert Spinner, M.D., the lead neurosurgeon on the Mayo Clinic team.

The team used a sophisticated magnetic resonance imaging (MRI) system performed on a 3-Tesla magnet to help identify suitable candidates for a complicated tumor-removal surgery. A 3-Tesla MRI system is one of the strongest commercially available.

A standardized surgical approach for safe and complete removal of sciatic notch dumbbell-shaped tumors has been problematic for at least three reasons. These tumors are comparatively rare and therefore hard to study; they are also anatomically hard to reach and remove without injuring the main sciatic nerve; and thirdly, they are difficult to visualize before surgery with enough detail to differentiate tumor boundaries from nerve. This study begins to change this situation by validating a new multidisciplinary approach for obtaining the desired favorable surgical outcomes.

With the 3-Tesla MRI images, Mayo Clinic surgeons from three specialties--neurosurgery, colorectal, and orthopedic surgery--obtained adequately detailed images of the tumor and nerve relationship before surgery in all five cases to accurately predict which patients would benefit from surgery. In three cases, the tumor was predicted to be distinct from the main sciatic nerve, and the tumor was effectively removed. All three patients experienced relief from pain and had no recurrent growth one year after surgery. In the other two instances, the tumor was predicted to be so tangled up in the nerve that surgery would have damaged the nerve. Those patients did not undergo surgery.



Related Links:
Mayo Clinic

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Immobilization System
Cranial 4Pi Immobilization
New
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.